The Magazine for Sleep Professionals
Thursday, February 5, 2026
Almost four years since the last guidance on the diagnosis and management of idiopathic pulmonary fibrosis, the American Thoracic Society – in collaboration with the European Respiratory Society, Japanese Respiratory Society and Asociacion Latinoamericana de Torax – has issued new guidelines for clinicians. The guidelines are available online in the May 1 issue […]
Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or death. While there were no statistical benefits for patients with the lung-scarring disease, the new research will prevent unnecessary […]
Two drugs to reduce the scarring of the lungs that occurs in patients with idiopathic pulmonary fibrosis (IPF) appear to increase longevity and decrease hospitalizations, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Clinical Effectiveness of the Anti-Fibrotic Medications […]
Discovery in Laboratory Mice Suggests Possible Role for Anti-Cancer Drugs in Treating Pulmonary Fibrosis A protein associated with cancer growth appears to drive the deadly lung disease known as idiopathic pulmonary fibrosis, according to new research from Cedars-Sinai. The discovery, made in laboratory mice and human tissue samples, may have […]
A new international guideline has been developed to help physicians diagnosis idiopathic pulmonary fibrosis (IPF), a rare and often fatal lung disease whose cause is unknown. The 2018 clinical practice guideline was developed by experts representing four major respiratory societies—the American Thoracic Society (ATS), the European Respiratory Society (ERS), Japanese […]
